Classification of duct carcinoma in situ (DCIS) with a characterization of high grade lesions: Defining cohorts for chemoprevention trials

Journal of Cellular Biochemistry

Volumn 63, Issue SUPPL. 25, 1996, Pages 108-111

  Lagios, Michael D ^a  

^a ST MARY S MEDICAL CENTER   (United States)

Author keywords

duct carcinoma in situ; invasive transformation; local recurrence; nuclear grade necrosis; prognostic features

Indexed keywords

ESTROGEN RECEPTOR; PROTEIN P53; ANTINEOPLASTIC AGENT;

ANEUPLOIDY; ARTICLE; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER PREVENTION; CARCINOMA IN SITU; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; BREAST TUMOR; CANCER STAGING; CHEMOPROPHYLAXIS; CLASSIFICATION; CLINICAL TRIAL; COHORT ANALYSIS; METHODOLOGY; PAGET NIPPLE DISEASE; PATHOLOGY; REVIEW;

ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CHEMOPREVENTION; CLINICAL TRIALS; COHORT STUDIES; HUMANS; NEOPLASM STAGING;

EID: 0030338094     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(1996)25+<108::AID-JCB15>3.0.CO;2-K     Document Type: Article

References (21)

1. Azzopardi JG (1979): Problems in breast pathology. Philadelphia: W.B. Saunders :466.
2. Ashikari R, Hajdu SI, Robbins GF, et al. (1971): Intraductal carcinoma of the breast (1960-1969). Cancer 28:1182-87.
3. Lagios MD, Westdahl PR, Margolin FR, Rose MR (1982): Duct carcinoma in situ: Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 50:1309-14.
4. Lagios, MD, Margolin FR, Westdahl PR, Rose MR (1989): Mammographically detected duet carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 63:619-624.
5. Solin LJ, Yeh I-T, Kurtz J, Fourquet A, Abram R, Kuse R, McCormick B, Cross M, Schultz D, Amalric R, LiVolsi V, Kowalyshyn M, Torhorst J, Jacquemier J, Westermann C, Mazoujian G, Zafrani B, Rosen PP, Goodman RL, Fowble B (1993): Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation: Correlation of pathologic parameters with outcome of treatment. Cancer 1(8):2532-2542.
6. Silverstein MJ, Poller DN, Waisman Joseph G. Roche, M.D., Colburn WJ, Barth A, Gierson ED, Lewinsky B, Gamagami P, Slamon DJ (1995): Prognostic classification of breast ductal carcinoma in situ. Lancet (May 6) 345(8958):1154-7.
7. Fisher B, Costantino J, Redmond C, Fisher E, Margolese R, Dimitrov N, Wolmark N, Wickerham DL, Deutsch M, Ore L, Mamounas E, Poller W, Kavanah M (1993): Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Eng J Med 328:1581-1586.
8. Duct carcinoma in situ: Controversies in diagnosis, biology and treatment. The Breast Journal 1995: Vol 1, No. 2, 68-78.
9. Ottesen GL, Graversen HP, Bilcher-Toft M, Zedeler K, Andersen JA (1992): Ductal carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. Amer J Surg Path 16:1183-1196.
10. Bellamy COC, McDonald D, Salter DM, Chetly U, Anderson TJ (1993): Non-invasive ductal carcinoma of the breast. The relevance of histologie categorization. Hum Pathol 24:16-23.
11. Silverstein MJ, Waisman JR, Gierson ED, Colburn W, Gamagami P, Lewinsky BS (1991): Radiation therapy for intraductal carcinoma. Is it an equal alternative? Arch Surg 126:424-428.
12. Schwartz GF, Finkel GC, Garcia JG and Patchefsky AS (1992): Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone. Cancer 70:2468-2474.
13. Patchefsky AS, Schwartz GF, Finkelstein SD, Prestipino A, Sohn SE, Singer JS, Feig SA (1989): Heterogeneity of intraductal carcinoma of the breast. Cancer 63:731-741.
14. Lagios MD (1990): Duct carcinoma in situ: Pathology and treatment. Surg Clin North Am 70:853-871.
15. Poller DN, Silverstein MJ, Galea M, Locker AP, Elston WE, Blamey RW, Ellis IO (1994): Ductal carcinoma in situ of the breast: A proposal for a new simplified histological classification association between cellular proliferation and c-erb-2 protein expression. Modern Path 7(2):257.
16. Zafrani B, Leroyer A, Forquet A, Laurent M, Trophilme D, Validire P, Sastre-Garau X (1994): Mammographically detected ductal carcinoma in situ of the breast analyzed with a new classification. A study of 127 cases: Correlation with estrogen and progesterone receptors, p53 and CerB-2 proteins and proliferative activity. Semin Diagn Path 11:208-214.
17. Fisher ER, Constantino J, Fisher B, Palekar ES, Redmond C, Mamounas E (1995): Pathologic findings from the national surgical adjuvant breast protocol B-17; intraductal carcinoma (duct carcinoma in situ). Cancer (75)6:1310-1319.
18. Holland R, Peterse JL, Millis RR, Eusebi V, Faverly D, van de Vijver MJ, Zafrani B (1994): Ductal carcinoma in situ: A proposal for new classification. Semin Diagn Path 11:167-180.
19. Bobrow LG, Happerfield LC, Gregory WM, Springall RD, Millis RR (1994): The classification of ductal carcinoma in situ and its association with biological markers. Semin Diag Path 11(3):199-207.
20. Tavassoli FA, Norris HJ (1990): A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 65:518-529.
21. Silverstein MJ, Lagios MD, Craig PH, et al. (1996): A prognostic index of ductal carcinoma in situ of the breast. Cancer 77:1167-1174.